Improvement of glycemic control in patients with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The recommended doses of this medicine for antidiabetic therapy are dapagliflozin 10 mg and sitagliptin 100 mg. The dose of extended-release metformin hydrochloride, not exceeding 2000 mg, should be determined considering each patient's current treatment regimen, efficacy, and tolerability.
To reduce gastrointestinal adverse reactions caused by metformin hydrochloride, this medicine should be taken once daily in the evening with a meal.
Patients taking this medicine as a 10/100/1000 mg extended-release tablet should take one tablet once daily; for the 5/50/1000 mg extended-release tablet, take two tablets together once daily.
To maintain the extended-release properties, swallow whole; do not split, crush, grind, or chew.
Improvement of glycemic control in patients with type 2 diabetes mellitus
View approved original textHide original text
This medication is used to assist in blood sugar control in patients with type 2 diabetes when used in conjunction with dapagliflozin, sitagliptin, and metformin. When taken alongside dietary and exercise therapy, it can effectively improve blood sugar levels. This helps manage diabetes and contributes to maintaining a healthy lifestyle.
How to take
Adult dose
The recommended doses of this medicine for antidiabetic therapy are dapagliflozin 10 mg and sitagliptin 100 mg. The dose of extended-release metformin hydrochloride, not exceeding 2000 mg, should be determined considering each patient's current treatment regimen, efficacy, and tolerability.
To reduce gastrointestinal adverse reactions caused by metformin hydrochloride, this medicine should be taken once daily in the evening with a meal.
Patients taking this medicine as a 10/100/1000 mg extended-release tablet should take one tablet once daily; for the 5/50/1000 mg extended-release tablet, take two tablets together once daily.
To maintain the extended-release properties, swallow whole; do not split, crush, grind, or chew.
Precautions
This medication is a diabetes treatment that combines three components: sitagliptin, dapagliflozin, and metformin.
Firstly, the sitagliptin component can rarely cause serious allergic reactions. If you notice symptoms such as skin rash, difficulty breathing, or facial swelling after taking it, you should immediately stop taking the medication and consult a physician.
Additionally, acute pancreatitis, a condition involving inflammation of the pancreas, may occur, so if you experience severe abdominal pain, vomiting, or fever, you should visit a hospital right away.
Next, metformin can rarely cause severe metabolic disorder known as lactic acidosis. If sudden difficulty in breathing, muscle pain, weakness, or abdominal pain occurs, you must inform your healthcare provider immediately.
This medication should not be used in patients with moderate or severe renal impairment or in cases of dehydration, severe infection, acute myocardial infarction, sepsis, or acute heart failure.
Particularly before and after any imaging procedures using contrast agents, it is advisable to temporarily discontinue use due to the risk of worsening renal function and lactic acidosis, as well as to pause the medication before and after surgical procedures for safety.
During treatment, symptoms such as low blood pressure and decreased fluid volume may occur, so watch for dizziness and signs of dehydration. Elderly patients or those with compromised renal function should be monitored more closely.
Moreover, this medication may increase the risk of genital and urinary tract infections, and proper treatment should be sought if any signs of infection arise.
When used in conjunction with other medications for blood sugar control, the risk of hypoglycemia may increase. Immediate action should be taken if symptoms of hypoglycemia such as cold sweat, trembling, headache, or confusion arise.
Routine evaluations of liver and kidney function should be conducted while taking this medication, and if any signs of abnormality appear, you must inform healthcare personnel immediately.
If you experience fever, pain in the genital or perineal area, redness, or swelling during treatment, it could indicate serious perineal necrosis disease, and immediate treatment should be sought.
Finally, it is advisable to avoid alcohol consumption during treatment with this medication. If fluid volume decreases, dehydration, or acute illness occur, temporarily discontinuing the medication and consulting a physician is recommended.
Side effects
Severe allergic reactions
anaphylaxis
angioedema
Stevens-Johnson syndrome
acute pancreatitis
hemorrhagic pancreatitis
necrotizing pancreatitis
lactic acidosis
hypoglycemia
genital infections
Show 112 moreCollapse
vulvitis
balanitis
fungal infections
perineal necrosis
decreased fluid volume
dry mouth
diabetic ketoacidosis
dizziness
constipation
dry mouth
back pain
dysuria
polyuria
nocturia
interstitial nephritis
elevated hematocrit
increased serum creatinine
elevated blood urea
dyslipidemia
urinary tract infections
decreased renal creatinine clearance
renal impairment
elevated blood creatinine
worsening renal function
rash
generalized rash
pruritic rash
maculopapular rash
pustular rash
vesicular rash
erythematous rash
gastroesophageal reflux disease
upper abdominal pain
diverticulosis
intestinal perforation
chronic pancreatitis
hyperglycemia
paresthesia
cerebral infarction
nerve compression
sinusitis
diverticulitis
pelvic inflammatory disease
pneumonia
pulmonary tuberculosis
weakness
pain
ligament sprain
traffic accident
drug overdose
ankle fracture
hand fracture
pelvic fracture
meniscal injury
thoracic vertebra fracture
tibial fracture
keratitis
chronic obstructive pulmonary disease
hemoptysis
cerebral hemorrhage
peripheral artery occlusion
angina
myocardial infarction
bile duct stones
cholangitis
alcoholic cirrhosis
depression
suicide attempt
gastric adenocarcinoma
anaphylactic reaction
acute pyelonephritis
chest pain
dyspepsia
nausea
diarrhea
vomiting
urinary retention
increased alanine aminotransferase
increased aspartate aminotransferase
decreased appetite
subsequent phenomenon
headache
nasopharyngitis
chest discomfort
peripheral edema
generalized edema
hunger
vaginal discharge
menstrual irregularity
pruritus
urticaria
cold sweat
arthralgia
musculoskeletal pain
limb pain
muscle weakness
myalgia
osteoarthritis
ligament sprain
diabetic retinopathy
cough
dyspnea
orthostatic hypotension
palpitations
insomnia
fatty liver
gallbladder polyps
tinnitus
taste impairment
erythema
urticaria
rash
Not everyone experiences these, and they can vary from person to person.
Storage
This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It is recommended to maintain room temperature between 1 degree and 30 degrees Celsius.
Appearance and packaging
Appearance
Yellow to deep yellow, oval-shaped prolonged-release film-coated tablets with both sides convex
Package unit
Bottle - 30 tablets/bottle
Same-ingredient medicines
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
Questions about this medicine
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety. Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.